Clinical Trial Update: Phase Ia Clinical Study of HDM1005 Injection [Phase 1]

View source ↗

Summary

This document reports the completion of a Phase Ia clinical study of the HDM1005 Injection for obesity and overweight. No efficacy data is provided in the snipp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Overweight

Drugs mentioned

• HDM1005 Injection

Snippet

Sponsor: Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. | Conditions: Obesity and Overweight | Phase 1 | Status: COMPLETED